137 related articles for article (PubMed ID: 25989345)
1. A facile synthesis of novel miconazole analogues and the evaluation of their antifungal activity.
Ramírez-Villalva A; González-Calderón D; González-Romero C; Morales-Rodríguez M; Jauregui-Rodríguez B; Cuevas-Yáñez E; Fuentes-Benítes A
Eur J Med Chem; 2015 Jun; 97():275-9. PubMed ID: 25989345
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
Gebhart RJ; Espinel-Ingroff A; Shadomy S
Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazole derivatives.
Foroumadi A; Daneshtalab M; Shafiee A
Arzneimittelforschung; 1999 Dec; 49(12):1035-8. PubMed ID: 10635451
[TBL] [Abstract][Full Text] [Related]
5. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
[TBL] [Abstract][Full Text] [Related]
6. Studies on antifungal agents. In vitro activity of novel cis-5-alkoxy (or acyloxy)alkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivatives.
Maryniak DM; Mullen GB; Allen SD; Mitchell JT; Kinsolving CR; St Georgiev V
Arzneimittelforschung; 1990 Jan; 40(1):95-8. PubMed ID: 2340006
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives.
Na YM; Le Borgne M; Pagniez F; Le Baut G; Le Pape P
Eur J Med Chem; 2003 Jan; 38(1):75-87. PubMed ID: 12593918
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents. VIII. Synthesis and antifungal activities of bipyrryl analogues of bifonazole.
di Santo R; Massa S; Costi R; Simonetti G; Retico A; Apuzzo G; Troccoli F
Farmaco; 1994 Apr; 49(4):229-36. PubMed ID: 8049002
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Marco F; Pfaller MA; Messer SA; Jones RN
Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial properties of 3-aryl-1-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-yl)propanes as 'carba-analogues' of the N-arylmethyl-N-[(1,1'-biphenyl)-4-ylmethyl])-1H-imidazol-1-amines, a new class of antifungal agents.
Castellano S; Stefancich G; Chillotti A; Poni G
Farmaco; 2003 Aug; 58(8):563-8. PubMed ID: 12875886
[TBL] [Abstract][Full Text] [Related]
12. Rational design of antimicrobial agents: antifungal activity of alk(en)yl dihydroxybenzoates and dihydroxyphenyl alkanoates.
Nihei K; Nihei A; Kubo I
Bioorg Med Chem Lett; 2003 Nov; 13(22):3993-6. PubMed ID: 14592492
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antifungal activity evaluation of 3-hydroxyimidazo[1,2-a]pyridine and 3-hydroxyimidazo[1,2-a]pyrimidine derivatives.
Rival Y; Taudou A; Ecalle R
Farmaco; 1993 Jun; 48(6):857-69. PubMed ID: 8373508
[No Abstract] [Full Text] [Related]
14. Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
Mullen GB; DeCory TR; Mitchell JT; Allen SD; Kinsolving CR; Georgiev VS
J Med Chem; 1988 Oct; 31(10):2008-14. PubMed ID: 3172137
[TBL] [Abstract][Full Text] [Related]
15. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives.
Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G
Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of substituted pyrimidines, pyrazole[3,4-d]pyrimidines and imidazo[4,5-d]pyrimidines and evaluation of their antifungal activity.
Ronsisvalle G; Pappalardo MS; Vittorio F; Pasquinucci L; Bousquet E; Oliveri S; Cammarata E
Farmaco; 1989 Apr; 44(4):383-90. PubMed ID: 2775419
[TBL] [Abstract][Full Text] [Related]
17. Imidazole analogues of fluoxetine, a novel class of anti-Candida agents.
Silvestri R; Artico M; La Regina G; Di Pasquali A; De Martino G; D'Auria FD; Nencioni L; Palamara AT
J Med Chem; 2004 Jul; 47(16):3924-6. PubMed ID: 15267229
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antifungal activity of new derivatives of 5-(4-halobenzoyl)-4-amino-3-(2-dialkylaminoethylthio)thieno [2,3-c] and [3,2-d] isothiazole].
Romeo G; Bousquet E; Pappalardo MS; Ronsisvalle G; Oliveri S; Cammarata E
Farmaco Sci; 1988 May; 43(5):457-67. PubMed ID: 3220129
[TBL] [Abstract][Full Text] [Related]
19. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
Otcenásek M
J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):129-34. PubMed ID: 2170505
[TBL] [Abstract][Full Text] [Related]
20. Novel high energy intermediate analogues with triazasterol-related structures as inhibitors of ergosterol biosynthesis. Part I: synthesis and antifungal activity of N-alkyl-N'-(phenethyl- and cyclohexenylethyl)guanidines and N2-substituted 2-imidazolinamines.
Gössnitzer E; Malli R; Schuster S; Favre B; Ryder NS
Arch Pharm (Weinheim); 2002; 335(11-12):535-46. PubMed ID: 12596218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
